GT Medical Technologies
PrivateLast Round
Series E
Jun 9, 2026
Total Funding Raised
$262M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GT Medical Technologies is a medical device company that develops innovative therapeutic solutions, including the FDA-cleared GammaTile Therapy, to improve outcomes for patients with operable brain tumors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GT Medical Technologies Comparables
Compare GT Medical Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alpha Tau Medical | 76% | |
| Azurity Pharmaceuticals | 75% | |
| ZAP Surgical Systems | 73% |
GT Medical Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jun 9, 2026 | ||||
| Series D | Jul 15, 2025 | ||||
| Debt | Sep 12, 2024 | ||||
| Series C | Mar 23, 2023 | ||||
| Series B | Nov 23, 2020 | ||||
Series A | Feb 1, 2019 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
BID | |||||
BID |
Key People
Founding team and executive leadership
GT Medical Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Evidity Health Capital | Series E, Series D |
| Gilde Healthcare | Series E, Series D, Series C |
| Medical Technology Venture Partners | Series E, Series D, Series C, Series B, Series A, Seed |
| Warren Point Capital | Series D |
| Viking Global Investors | Series E |
| Horizon Technology Finance Corporation | Debt |
| BlueStone Venture Partners | Series A, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
$100M round led by Viking Global Investors
- Jul 15, 2025
$53M round completed.
GT Medical Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GT Medical Technologies's valuation, stock price, and market status.
Is GT Medical Technologies a public or private company?
GT Medical Technologies is a private company.
What is the current stock price of GT Medical Technologies?
GT Medical Technologies is a private company with no public stock price. No recent secondary market data is available.
How much is GT Medical Technologies worth (valuation)?
Valuation information for GT Medical Technologies is not publicly available.
Can I buy GT Medical Technologies stock?
GT Medical Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GT Medical Technologies's last funding round?
GT Medical Technologies's most recent funding round was Series E on June 9, 2026.
Who are the main investors in GT Medical Technologies?
Key investors in GT Medical Technologies include Evidity Health Capital, Viking Global Investors, MVM Life Science Partners LLP.
Will GT Medical Technologies IPO soon?
No public IPO plans have been announced for GT Medical Technologies.
How can I track GT Medical Technologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GT Medical Technologies's secondary market activity and sign up for updates.